Abiopharma

Stitch Fix Appoints Sree Sreedhararaj as Chief Product and Technology Officer

Safehold Closes $225 Million Private Placement of Structured Senior Unsecured Notes Due 2056

Chegg Reports New Hire Equity Grants Under NYSE Rule 303A.08

Domo Announces First Quarter Fiscal 2027 Financial Results and Provides Strategic Alternatives Process Update

Fastenal to Serve as a Partner of the 2026 Special Olympics USA Games

VOYA GLOBAL ADVANTAGE AND PREMIUM OPPORTUNITY FUND, VOYA GLOBAL EQUITY DIVIDEND AND PREMIUM OPPORTUNITY FUND & VOYA INFRASTRUCTURE, INDUSTRIALS AND MATERIALS FUND ANNOUNCES PAYMENT OF MONTHLY DISTRIBUTION

Citizens Financial Group Names Chris Emerson Head of Investor Relations

Allbirds Announces Record Date for the Asset Sale Dividend

J-Star Holding Announces Receipt of Nasdaq Delisting Determination; Class A Ordinary Shares Expected to Continue Trading Pending Nasdaq Hearings Panel Review

Neurocrine Biosciences Presents First Retrospective Case Series of CRENESSITY® (crinecerfont) in Patients with Classic Congenital Adrenal Hyperplasia Due to 11β‑Hydroxylase Deficiency at ENDO 2026